Past, Present and Future: SGLT2 inhibitors for CV Outcomes

  • Published:  17 August 2020
  • Likes: 

    Heart Icon

    0

Up Next

Past, Present and Future: SGLT2 inhibitors for CV Outcomes

  • Published:  17 August 2020
  • Likes: 

    Heart Icon

    0

Average (ratings)
No ratings
Your rating
Overview

This roundtable event includes four leading heart failure specialists discussing recent data related to SGLT2 inhibitors in reducing CV risk, HF hospitalisations and mortality and morbidity in HFrEF irrespective of T2DM. The panel also look at ongoing studies including those for HFpEF and CKD outcomes.

 

This video series was funded by an unrestricted educational grant from Boehringer Ingelheim.

Educational Objectives

  • Understand the History of SGLT2 Inhibitors and the Published Data from SGLT-2 Inhibitor Cardiovascular Outcome Trials (CVOT).
  • Link These Outcomes Data to the Latest Guideline Updates in Diabetes.
  • Understand the Importance of the Ongoing CREDENCE, EMPA and DAPA Clinical Trials.
  • Evaluate Emerging Data of the Treatment of HF With SGLT2 Inhibitors in Patients With or Without T2DM.
  • Apply This Clinical Understanding to the Management of Heart Failure Patients in the Real World.
  • Identify Important Future Developments to Be Aware of to Allow Continual Optimisation of Heart Failure Management and the Potential for Future Guideline Updates in Heart Failure
  • Assess the Interrelationships Linking Diabetes, HF and CVD

More from this programme

Part 1

How Did We Get Here?

Part 2

Where Are We Now?

Part 3

What Is the Future?

Faculty Biographies

Andrew JS Coats

Andrew JS Coats

Professor of Cardiology and Scientific Director

Professor Andrew Coats was born in Melbourne, Australia. He studied at St Catherine’s College, Oxford, where he earned a B.A. in Physiological Sciences with First-Class Honours, and then completed his medical degree (M.B. B.Chir.) at Clare College, Cambridge. He later obtained higher doctorates (D.M. and D.Sc.) in recognition of his substantial contributions to cardiovascular medicine, and he also completed an MBA at the London Business School. Professor Coats serves as Editor-in-Chief of the Cardiac Failure Review journal.

 

Career Overview

Andrew Coats is an internationally renowned academic cardiologist, inventor, and university leader with a career spanning more than three decades. He is currently the Scientific Director and CEO of the Heart Research Institute in Sydney, Australia. He also serves as Dean of the Royal Australasian College of Physicians, Affiliate Professor at Deakin University, and Emeritus Professor of Medicine at Monash University.

View full profile
Faiez Zannad

Faiez Zannad

Professor Emeritus; Founder and Chairman of CVCT Société Civile

Prof Faiez Zannad was born in Monastir, Tunisia in 1951 and later moved to pursue his medical education and research in Europe. He trained in cardiology and pharmacology across institutions in France and the United Kingdom, including Nancy, Lyon, and Oxford. Over the course of his career, he has lived and worked primarily in Nancy, France, where he has held clinical, academic, and research leadership roles in cardiovascular medicine and therapeutics.

 

Academic History

Prof Zannad earned his MD in cardiology from the Faculté de Médecine de Nancy and further trained as a research fellow in clinical pharmacology at the Medical Research Council in Oxford. He later received a PhD in cardiovascular clinical pharmacology from the University of Lyon. During his academic training, he focused on cardiovascular pharmacology, physiology, and therapeutic innovation, laying the foundation for his lifelong work in heart failure and hypertension research.

Following…

View full profile
Stefan Anker

Stefan Anker

Professor of Cardiology

Prof Stefan D Anker is a German cardiologist born in Berlin, Germany. He studied medicine at Charité Medical School of Humboldt University Berlin, where he completed his medical degree in 1993. He later pursued research training at the National Heart & Lung Institute, Imperial College London, completing his PhD in 1998. Following his return to Germany, Prof Anker held academic and research positions at Charité Berlin and later at University Medical Center Göttingen before returning to Charité in 2017 to serve as Professor of (Tissue) Homeostasis in Cardiology & Metabolism. His work has taken him across multiple institutions and countries through long-standing international collaborations.

 

Academic History

Prof Anker began his medical education at Charité Medical School, graduating in 1993. He then continued postgraduate academic training in both Germany and the United Kingdom, completing his PhD at the National Heart & Lung Institute in London…

View full profile
John JV McMurray

John JV McMurray

Professor of Cardiology

Prof John McMurray is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. A graduate of Manchester University, Prof McMurray completed postgraduate research at the University of Dundee.

Prof McMurray is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences.

View full profile